Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
All-Star voting winners: E-Day at the K celebrates KCSourceLink, its network (Photos)
KCSourceLink’s Entrepreneur Day at the K heralded the work of the support organization’s sprawling network of partners. But the tailgate party at Kauffman Stadium didn’t let founder Maria Meyers go unnoticed. Reading from a proclamation announcement marking Monday as “KCSourceLink Entrepreneur Day” in Kansas City, Missouri, Nathan Kurtz, entrepreneur advocate at the Ewing Marion Kauffman…
Vote now: KCMO competing for spot in accelerator focusing on gender, racial inclusion
KCMO already is a five-star city, Mayor Sly James says, but a new accelerator program could make it even better. “Kansas City’s startup community is growing and innovating, but women and people of color are being left behind,” James says in a pitch video for Living Cities City Accelerator program. A coalition of local organizations,…
Go print yourself! Overland Park doob shop turns selfie concept into 3D replicas
A new shop in Overland Park is supplanting the selfie with the mini me. After first opening shops in Los Angeles and New York City, the Germany-based 3D printing firm doob has arrived in the Kansas City area to 3D print people, groups and pets. The technology, process and results capture moments in time customers…
KCultivator Q&A: Reggie Gray finds magic in connecting entrepreneurs with Black Privilege, no excuses
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. The KCultivator Series is sponsored by WeWork Corrigan Station, a modern twist on Kansas City office space. He’s left his “Magic Man” persona behind, but Reggie Gray can’t quite shake the performer inside him, he said. “Whenever I…